| Expression pattern: |
UP |
| Associated gene: |
WNT5A, beta-catenin, c-Myc, cyclin D1 |
| Associated microRNA: |
miR-876-5p |
| Biological function: |
Promotes NSCLC cell proliferation, migration, invasion, stemness maintenance and tumor growth in vivo. |
| Molecular mechanism: |
CircVAPA functions as a competing endogenous RNA that sponges miR-876-5p, up-regulates WNT5A, and activates Wnt/beta-catenin signaling. |
| Biological pathway or process: |
Wnt/beta-catenin (promotes); proliferation (promotes); migration (promotes); invasion (promotes); stemness (promotes); ceRNA regulation (promotes); apoptosis (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; MTT; EdU Staining; Transwell Assay; Western Blot; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; Transfection; In Vivo Animal Model; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
High expression of circVAPA indicated a poor prognosis in patients with NSCLC; circVAPA may be a potential therapeutic target for NSCLC. |
| Description: |
hsa_circ_0006990, named circVAPA, is up-regulated in NSCLC tissues and cell lines and high expression predicts poor prognosis. It promotes malignant NSCLC phenotypes by sponging miR-876-5p to increase WNT5A expression, thereby activating Wnt/beta-catenin signaling. |
| Confidence score: |
0.817 |